As of 2026-09-29, the Relative Valuation of Dyne Therapeutics Inc (DYN) is (59.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 16.34 USD, the upside of Dyne Therapeutics Inc based on Relative Valuation is -461.3%.
The range of the Relative Valuation is (50.62) - (71.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 25.8x | 22.0x |
| Forward P/E multiples | 15.0x - 25.9x | 20.4x |
| Fair Price | (50.62) - (71.76) | (59.03) |
| Upside | -409.8% - -539.2% | -461.3% |
| Date | P/E |
| 2026-09-28 | -5.87 |
| 2026-09-25 | -5.76 |
| 2026-09-24 | -5.94 |
| 2026-09-23 | -5.84 |
| 2026-09-22 | -6.16 |
| 2026-09-21 | -6.16 |
| 2026-09-18 | -6.15 |
| 2026-09-17 | -6.49 |
| 2026-09-16 | -6.22 |
| 2026-09-15 | -6.44 |
| 2026-09-14 | -6.66 |
| 2026-09-11 | -6.55 |
| 2026-09-10 | -6.62 |
| 2026-09-09 | -6.90 |
| 2026-09-08 | -7.30 |
| 2026-09-04 | -8.73 |
| 2026-09-03 | -8.97 |
| 2026-09-02 | -9.04 |
| 2026-09-01 | -9.02 |
| 2026-08-31 | -9.14 |
| 2026-08-28 | -9.01 |
| 2026-08-27 | -9.38 |
| 2026-08-26 | -9.48 |
| 2026-08-25 | -9.47 |
| 2026-08-24 | -9.34 |
| 2026-08-21 | -9.38 |
| 2026-08-20 | -9.34 |
| 2026-08-19 | -9.63 |
| 2026-08-18 | -9.35 |
| 2026-08-17 | -9.40 |
| 2026-08-14 | -9.24 |
| 2026-08-13 | -9.33 |
| 2026-08-12 | -9.41 |
| 2026-08-11 | -9.60 |
| 2026-08-10 | -9.53 |
| 2026-08-07 | -9.44 |
| 2026-08-06 | -9.31 |
| 2026-08-05 | -9.41 |
| 2026-08-04 | -9.34 |
| 2026-08-03 | -9.07 |
| 2026-07-31 | -9.05 |
| 2026-07-30 | -9.25 |
| 2026-07-29 | -9.02 |
| 2026-07-28 | -9.31 |
| 2026-07-27 | -9.22 |
| 2026-07-24 | -8.79 |
| 2026-07-23 | -8.59 |
| 2026-07-22 | -8.35 |
| 2026-07-21 | -8.57 |
| 2026-07-20 | -8.43 |